Bruker Corporation. (9/7/18). "Press Release: Bruker Corporation to Present at the 16th Annual Morgan Stanley Global Healthcare Conference". Billerica, MA.

	Region	New York, NY
	Country	United States (USA)
	Organisation	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Organisation 2	Morgan Stanley & Co. LLC
	Group	Morgan Stanley (Group)
	Product	Morgan Stanley Global Healthcare Conference 2018 New York
	Product 2	analytical instrument
	Index term	Bruker–Morgan Stanley: investor conference, 201809 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Busse, Falko (Bruker Corp 201805– President of Bruker BioSpin Group joined 2015 before Philips Healthcare)

Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 16th Annual Morgan Stanley Global Healthcare Conference. Frank Laukien, President and Chief Executive Officer and Falko Busse, President of the Bruker BioSpin Group, will participate in a "fireside chat" Q&A session on behalf of the company on Thursday, September 13th, 2018 at 12:55 PM Eastern Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (NASDAQ: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

Contact :

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

Record changed: 2018-09-09